SCHEMBL29397204

SCHEMBL29397204

COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C1(C)CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 15/20 1.00
RARG P13631 15/20 1.00
RARA P10276 14/20 1.00
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
LMNA P02545 2/20 0.64
NR1I2 O75469 1/20 0.64
PGR P06401 1/20 0.64
HSPD1 P10809 1/20 0.64
GOT1 P17174 1/20 0.64
GLRA1 P23415 1/20 0.64
BLM P54132 1/20 0.64
HSPE1 P61604 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29358433 1.00 RARB (1.00) RARBRARGRARAMEN1KMT2A
SCHEMBL7928834 1.00 RARB (1.00) RARBRARGRARAMEN1KMT2A
SCHEMBL7689383 0.87 RARB (0.77) RARBRARGRARAMEN1KMT2A
Hydrochloric Acid SCHEMBL9738342 0.86 RARB (0.75) RARBRARGRARAMEN1KMT2A
SCHEMBL9944159 0.81 RARB (0.74) RARBRARGRARAMEN1KMT2A
SCHEMBL13980228 0.81 RARB (0.67) RARBRARGRARAMEN1KMT2A
SCHEMBL19639449 0.80 RARB (0.67) RARBRARGRARAMAPTSMN1; SMN2
SCHEMBL13980181 0.80 RARB (0.66) RARBRARGRARAMEN1KMT2A
SCHEMBL14566563 0.80 RARB (0.66) RARBRARGRARAMEN1KMT2A
SCHEMBL5827791 0.80 RARB (0.66) RARBRARGRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233842-B1 BICYCLOHETEROARYL-HETEROARYL-BENZOIC ACID COMPOUNDS AS RETINOIC ACID RECEPTOR BETA (RARB) AGONISTS KING S COLLEGE LONDON (GB) 2025-03-26 EP disclosed
EP-4401829-A1 COMPOSITIONS AND METHODS FOR MITIGATING ALCOHOL LIVER DISEASE Cornell University (US) 2024-07-24 EP disclosed
WO-2023044355-A1 COMPOSITIONS AND METHODS FOR MITIGATING ALCOHOL LIVER DISEASE CORNELL UNIVERSITY (US) 2023-03-23 WO disclosed
US-11584741-B2 Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation KING'S COLLEGE LONDON (GB) 2023-02-21 US disclosed
US-11401265-B2 Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists KING'S COLLEGE LONDON 2022-08-02 US disclosed
CN-109415356-B Crystalline forms of 4- (5- (4, 7-dimethylbenzofuran-2-yl) -1,2, 4-oxadiazol-3-yl) benzoic acid and methods for their preparation 伦敦皇家学院 2022-03-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11401265-B2 Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists RARB, RARA, RXRB RARB 1/4885RARG 4/4885RARA 2/4885
US-11584741-B2 Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation RARB, RXRB, RARA RARB 1/4885RARG 4/4885RARA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.